Fabtech Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2025 ,inter alia, to consider and approve Intimation regarding postponement ....

Results View source PDF Explain this filing

FABTECH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.0%Reaction day

₹201.48

prior close

₹204.43

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%+3.5% vs market

Medical Equipment & Supplies peers, median of 11sector-0.3%+3.3% vs sector

On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250 and 3.3 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

+0.1

15m

-0.2

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.0-0.5+3.5-0.3+3.3

Next day

+3.2-0.8+4.1-0.4+3.6

+13.7-0.4+14.1-0.6+14.3

+24.7-0.2+24.8-0.7+25.4

+19.2+0.3+18.9+1.2+18.1

+16.1+0.1+16.1+0.3+15.9

+17.6+0.8+16.8-0.5+18.1

15d

+22.6-1.2+23.7-5.4+28.0

+17.9-3.9+21.9-11.8+29.8

+3.7-5.0+8.7-6.3+10.1

-20.8-13.9-6.9-18.6-2.2

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 11Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Fabtech Technologies Ltd has postponed its Board meeting originally scheduled for October 23, 2025 to October 27, 2025. The delay is due to pending procedural formalities related to the Limited Review Report and Unaudited Financial Results of its wholly-owned foreign subsidiary, Fabtech Technologies LLC. The rescheduled meeting will consider and approve the unaudited standalone and consolidated financial results for Q1 (ended June 30, 2025) and Q2/half-year (ended September 30, 2025). The insider trading window remains closed until 48 hours after the results are declared.

Likely market impact

This is a routine procedural delay with no indication of negative business developments. Shareholders should expect the Q1 and Q2 FY26 results by October 27, 2025, with no immediate impact on the stock price expected from this announcement alone.

By the numbersConsolidated · Q2 FY26

	Q2 FY26	Year ago	Change
Revenue	₹121.5 Cr	—	—
Operating profit	₹28.08 Cr	—	—
Profit after tax	₹28.11 Cr	—	—
EBITDA margin	25.1%	—	—

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income. No year-ago figures on this basis yet, so no comparison.